- Home
- STG vs ELUT Comparison
STG vs ELUT Comparison
Compare STG & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- ELUT
- Stock Information
- Founded
- STG 2003
- ELUT 2015
- Country
- STG China
- ELUT United States
- Employees
- STG N/A
- ELUT N/A
- Industry
- STG Other Consumer Services
- ELUT Medical Specialities
- Sector
- STG Real Estate
- ELUT Health Care
- Exchange
- STG Nasdaq
- ELUT Nasdaq
- Market Cap
- STG 70.3M
- ELUT 73.2M
- IPO Year
- STG 2018
- ELUT 2020
- Fundamental
- Price
- STG $5.43
- ELUT $1.81
- Analyst Decision
- STG
- ELUT Strong Buy
- Analyst Count
- STG 0
- ELUT 2
- Target Price
- STG N/A
- ELUT $8.00
- AVG Volume (30 Days)
- STG 4.7K
- ELUT 25.1K
- Earning Date
- STG 08-15-2025
- ELUT 08-06-2025
- Dividend Yield
- STG N/A
- ELUT N/A
- EPS Growth
- STG N/A
- ELUT N/A
- EPS
- STG 3.09
- ELUT N/A
- Revenue
- STG $269,356,990.00
- ELUT $23,711,000.00
- Revenue This Year
- STG N/A
- ELUT $20.10
- Revenue Next Year
- STG N/A
- ELUT $85.89
- P/E Ratio
- STG $1.76
- ELUT N/A
- Revenue Growth
- STG N/A
- ELUT N/A
- 52 Week Low
- STG $4.25
- ELUT $1.61
- 52 Week High
- STG $11.06
- ELUT $5.24
- Technical
- Relative Strength Index (RSI)
- STG 49.16
- ELUT 45.88
- Support Level
- STG $6.05
- ELUT $1.72
- Resistance Level
- STG $6.23
- ELUT $1.96
- Average True Range (ATR)
- STG 0.35
- ELUT 0.15
- MACD
- STG -0.07
- ELUT 0.01
- Stochastic Oscillator
- STG 8.69
- ELUT 24.13
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.